1. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet 2010;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6, PMID 20083042.
2. Shim YS, Morris JC. Biomarkers predicting Alzheimer’s disease in cognitively normal aging. J Clin 2011;7(2):60-8. doi: 10.3988/jcn.2011.7.2.60, PMID 21779293.
3. Cummings JL, Morstorf T, Zhong K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res 2014;6(4):37. doi: 10.1186/alzrt269, PMID 25024750.
4. Anderson RM, Hadjichrysanthou C, Evans S, Wong MM. Why do so many clinical trials of therapies for Alzheimer’s disease fail? Lancet. 2017;390(10110):2327-9. doi: 1016/S0140-6736(17)32399-1, PMID 29185425.
5. Schott JM, Aisen PS, Cummings JL, Howard RJ, Fox NC. Unsuccessful trials of therapies for Alzheimer’s disease. Lancet. 2019;393(10166):29. doi: 1016/S0140-6736(18)31896-8, PMID 30614456.
6. Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, et al, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Clinical core of the Alzheimer’s disease neuroimaging initiative: progress and plans. Alzheimers 2010;6(3):239-46. doi: 10.1016/j.jalz.2010.03.006, PMID 20451872.
7. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, et al, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M, Alzheimer's Disease Neuroimaging Initiative. The Alzheimer’s Disease Neuroimaging Initiative: progress re-port and future plans. Alzheimers 2010;6(3):202-11.e7. doi: 10.1016/j.jalz.2010.03.007, PMID 20451868.
8. Qiu Y, Li L, Zhou TY, Lu W, Alzheimer's Disease Neuroimaging Initiative. Alzheimer’s disease progression model based on integrated biomarkers and clinical measures. Acta Pharmacol 2014;35(9):1111-20. doi: 10.1038/aps.2014.57, PMID 25088003.
9. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys 1994;66(1):259-67. doi: 10.1016/S0006-3495(94)80775-1, PMID 8130344.
10. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson 1996;36(6):893-906. doi: 10.1002/mrm.1910360612, PMID 8946355.
11. Bozzali M, Cercignani M, Sormani MP, Comi G, Filippi M. Quantification of brain gray matter damage in different ms phenotypes by use of diffusion tensor MR imaging. AJNR Am J 2002;23(6):985-88. PMID 12063230.
12. Coleman MP, Freeman MR. Wallerian degeneration, wld(s), and nmnat. Annu Rev 2010;33:245-67. doi: 10.1146/annurev-neuro-060909-153248, PMID 20345246.
13. Montal V, Vilaplana E, Alcolea D, Pegueroles J, Pasternak O, González-Ortiz S, et al., Clarimón J, Carmona-Iragui M, Illán-Gala I, Morenas-Rodríguez E, Ribosa-Nogué R, Sala I, Sánchez-Saudinós MB, García-Sebastian M, Villanúa J, Izagirre A, Estanga A, Ecay-Torres M, Iriondo A, Clerigue M, Tainta M, Pozueta A, González A, Martínez-Heras E, Llufriu S, Blesa R, Sanchez-Juan P, Martínez-Lage P, Lleó A, Fortea J. Cortical microstructural changes along the Alzheimer’s disease continuum. Alzheimers 2018;14(3):340-51. doi: 10.1016/j.jalz.2017.09.013, PMID 29080407.
14. Illán‐Gala I, Montal V, Borrego‐Écija S, et al, Vilaplana E, Pegueroles J, Alcolea D,et al, Catalan Frontotemporal Dementia Initiative (CATFI) and the Frontotemporal Lobar Degeneration Neuroimaging Initiative (FTLDNI). Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy. Brain. 2019;142(4):1121-33. doi: 1093/brain/awz031, PMID 30906945.
15. Lee P, Ryoo H, Park J, Jeong Y, Alzheimer’s Disease Neuroimaging Initiative. Morphological and microstructural changes of the hippocampus in early MCI: A study utilizing the Alzheimer’s Disease Neuroimaging Initiative database. J Clin 2017;13(2):144-54. doi: 10.3988/jcn.2017.13.2.144, PMID 28176504.
16. Henf J, Grothe MJ, Brueggen K, Teipel S, Dyrba M. Mean diffusivity in cortical gray matter in Alzheimer’s disease: the importance of partial volume correction. NeuroImage 2018;17:579-86. doi: 10.1016/j.nicl.2017.10.005, PMID 29201644.
17. Lee P, Kim HR, Jeong Y. Disruption of gray matter microstructure in Alzheimer’s disease continuum using fiber orientation International Conference of Korean Dementia Association. 133:FP-0007; 2019.
18. McKavanagh R, Torso M, Jenkinson M, et al, Kolasinski J, Stagg CJ, Esiri MM, et al. Relating diffusion tensor imaging measurements to microstructural quantities in the cerebral cortex in multiple sclerosis. Hum Brain 2019;40(15):4417-31. doi: 10.1002/hbm.24711, PMID 31355989.
19. Eaton-Rosen Z, Scherrer B, Melbourne A, Ourselin S, Neil JJ, Warfield SK. Investigating the maturation of microstructure and radial orientation in the preterm human cortex with diffusion MRI. Neuroimage. 2017;162:65-72. doi: 1016/j.neuroimage.2017.08.013, PMID 28801253.
20. Kroenke CD. Using diffusion anisotropy to study cerebral cortical gray matter development. J Magn 2018;292:106-16. doi: 10.1016/j.jmr.2018.04.011, PMID 29705039.
21. Dean DC III, O’Muircheartaigh J, Dirks H, et al, Travers BG, Adluru N, Alexander AL, et al. Mapping an index of the myelin g‐ratio in infants using magnetic resonance imaging. Neuroimage. 2016;132:225-37. doi: 1016/j.neuroimage.2016.02.040, PMID 26908314.
22. McNab JA et al, Polimeni JR, Wang R, Augustinack JC, Fujimoto K, Stevens A, et al. Surface based analysis of diffusion orientation for identifying architectonic domains in the in vivo human cortex. NeuroImage. 2013;69:87-100. doi: 1016/j.neuroimage.2012.11.065, PMID 23247190.
23. Cardillo G. ROC curve: compute a Receiver Operating Characteristics curve. GitHub; 2020. Available from: https://github.com/dnafinder/roc.
24. Fukutomi H, Glasser MF, Zhang H, Autio JA, Coalson TS, Okada T, et al, et al. Neurite imaging reveals microstructural variations in the human cerebral cortical gray matter. Neuroimage. 2018;182:488-99. doi: 1016/j.neuroimage.2018.02.017, PMID 29448073.
25. Wu D et al, Reisinger D, Xu J, Fatemi SA, van Zijl PC, Mori S, et al. Localized diffusion magnetic resonance micro-imaging of the live mouse brain. Neuroimage. 2014;91:12-20. doi: 1016/j.neuroimage.2014.01.014, PMID 24440780.
26. Szczepankiewicz F et al, Lasič S, van Westen D, Sundgren PC, Englund E, Westin CF, et al. Quantification of microscopic diffusion anisotropy disentangles effects of orientation dispersion from microstructure: applications in healthy volunteers and in brain tumors. Neuroimage. 2015;104:241-52. doi: 1016/j.neuroimage.2014.09.057, PMID 25284306.
27. Koo BB, Hua N, Choi CH, Ronen I, Lee JM, Kim DS. A framework to analyze partial volume effect on gray matter mean diffusivity measurements. Neuroimage. 2009;44(1):136-44. doi: 1016/j.neuroimage.2008.07.064, PMID 18775785.
28. Truong TK, Guidon A, Song AW. Cortical depth dependence of the diffusion anisotropy in the human cortical gray matter in vivo. PLOS ONE. 2014;9(3):e91424. doi: 1371/journal.pone.0091424, PMID 24608869.
29. Marín-Padilla M. Ontogenesis of the pyramidal cell of the mammalian neocortex and developmental cytoarchitectonics: a unifying theory. J Comp 1992;321(2):223-40. doi: 10.1002/cne.903210205, PMID 1500541.
30. Callaway EM, Katz LC. Emergence and refinement of clustered horizontal connections in cat striate cortex. J 1990;10(4):1134-53. doi: 10.1523/JNEUROSCI.10-04-01134.1990, PMID 2329372.
31. Ghosh A, Shatz CJ. A role for subplate neurons in the patterning of connections from thalamus to neocortex. Development. 1993;117(3):1031-47. PMID 8325233.
32. Rivkin MJ, Flax J, Mozell R, Osathanondh R, Volpe JJ, Villa-Komaroff L. Oligodendroglial development in human fetal cerebrum. Ann 1995;38(1):92-101. doi: 10.1002/ana.410380116, PMID 7611731.
33. Hardy RJ, Friedrich VL Jr. Oligodendrocyte progenitors are generated throughout the embryonic mouse brain, but differentiate in restricted foci. Development. 1996;122(7):2059-69. PMID 8681787.
34. Pegueroles J, Vilaplana E, Montal V, Sampedro F, Alcolea D, Carmona-iragui M, et al, Clarimon J, Blesa R, Lleó A, Fortea J, Alzheimer's Disease Neuroimaging Initiative. Longitudinal brain structural changes in preclinical Alzheimer disease. Alzheimers 2017;13(5):499-509. doi: 10.1016/j.jalz.2016.08.010, PMID 27693189.
35. Vogt NM et al., Hunt JF, Adluru N, Dean DC, Johnson SC, Asthana S, et al. Cortical microstructural alterations in mild cognitive impairment and Alzheimer’s disease dementia. Cereb Cortex. 2020;30(5):2948-60. doi: 1093/cercor/bhz286, PMID 31833550.
36. Marzban EN, Eldeib AM, Yassine IA, Kadah YM, Alzheimer’s Disease Neurodegenerative Initiative, for the Alzheimer’s Disease Neurodegenerative Initiative. Alzheimer’s disease diagnosis from diffusion tensor images using convolutional neural networks. PLOS ONE. 2020;15(3):e0230409. doi: 1371/journal.pone.0230409, PMID 32208428.
37. Wen J, Samper-González J, Bottani S, Routier A, Burgos N, Jacquemont T, et al, et al. Reproducible evaluation of diffusion MRI features for automatic classification of patients with Alzheimer’s disease. Neuroinformatics. 2020. doi: 1007/s12021-020-09469-5, PMID 32524428.
38. Fortin JP, Parker D, Tunç B, Watanabe T, Elliott MA, Ruparel K, et al. Harmonization of multi-site diffusion tensor imaging data. Neuroimage. 2017;161:149-70. doi: 1016/j.neuroimage.2017.08.047, PMID 28826946.
39. Jack CR Jr et al, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers 2018;14(4):535-62. doi: 10.1016/j.jalz.2018.02.018, PMID 29653606.